📊 SSII Key Takeaways
Is SS Innovations International, Inc. (SSII) a Good Investment?
SSII exhibits severe fundamental weakness with stagnant revenue (0% YoY growth), deep operating losses (-32.8% margin), and negative operating cash flow (-$2.3M annually). Despite marginal YoY profitability improvements and healthy 48% gross margins, the company remains fundamentally unprofitable and is burning cash unsustainably against a depleting $16M reserve base.
SS Innovations International, Inc. Key Strengths (SSII)
- Strong gross margin of 48% demonstrates viable core product economics
- Excellent near-term liquidity with 2.54x current ratio and $16M cash on balance sheet
- Clean balance sheet with zero long-term debt and no debt service burden
SSII Stock Risks: SS Innovations International, Inc. Investment Risks
- Complete revenue stagnation at 0% YoY growth indicating lack of market traction or demand
- Severe operating losses (-32.8% margin) with -$3.6M operating loss proving core business is unprofitable
- Negative operating cash flow of -$2.3M annually consuming ~14% of cash reserves annually at unsustainable pace
Key Metrics to Watch
- Revenue growth rate - must achieve positive YoY growth to validate business model viability
- Operating margin trend - current -32.8% unsustainable; requires clear path to profitability
- Operating cash flow inflection - must turn positive to demonstrate sustainable operations without burning reserves
SS Innovations International, Inc. (SSII) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Strong liquidity with a 2.54x current ratio provides a solid financial cushion.
SSII Profit Margin, ROE & Profitability Analysis
SSII vs Healthcare Sector: How SS Innovations International, Inc. Compares
How SS Innovations International, Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is SS Innovations International, Inc. Stock Overvalued? SSII Valuation Analysis 2026
Based on fundamental analysis, SS Innovations International, Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
SS Innovations International, Inc. Balance Sheet: SSII Debt, Cash & Liquidity
SSII Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: SS Innovations International, Inc.'s revenue has remained relatively flat over the 5-year period, with a 0% decline. The most recent EPS of $-0.11 indicates the company is currently unprofitable.
SSII Revenue Growth, EPS Growth & YoY Performance
SSII Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $5.1M | -$3.6M | $-0.02 |
| Q3 2025 | $4.4M | -$3.2M | $-0.02 |
| Q2 2025 | $4.5M | -$256.7K | $0.00 |
| Q1 2025 | $3.6M | -$5.7M | $-0.03 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
SS Innovations International, Inc. Dividends, Buybacks & Capital Allocation
SSII SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for SS Innovations International, Inc. (CIK: 0001676163)
📋 Recent SEC Filings
❓ Frequently Asked Questions about SSII
What is the AI rating for SSII?
SS Innovations International, Inc. (SSII) has an AI grade of C with 88% confidence, based on fundamental analysis of SEC EDGAR filings.
What are SSII's key strengths?
Claude: Strong gross margin of 48% demonstrates viable core product economics. Excellent near-term liquidity with 2.54x current ratio and $16M cash on balance sheet.
What are the risks of investing in SSII?
Claude: Complete revenue stagnation at 0% YoY growth indicating lack of market traction or demand. Severe operating losses (-32.8% margin) with -$3.6M operating loss proving core business is unprofitable.
What is SSII's revenue and growth?
SS Innovations International, Inc. reported revenue of $11.1M.
Does SSII pay dividends?
SS Innovations International, Inc. does not currently pay dividends.
Where can I find SSII SEC filings?
Official SEC filings for SS Innovations International, Inc. (CIK: 0001676163) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is SSII's EPS?
SS Innovations International, Inc. has a diluted EPS of $-0.02.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is SSII's fundamental grade?
Based on our AI fundamental analysis in May 2026, SS Innovations International, Inc. has a C grade with 88% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is SSII stock overvalued or undervalued?
Valuation metrics for SSII: ROE of -6.6% (sector avg: 15%), net margin of -32.3% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
What is SSII's AI grade for 2026?
Our dual AI analysis gives SS Innovations International, Inc. a combined C grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is SSII's free cash flow?
SS Innovations International, Inc.'s operating cash flow is $-2.3M, with capital expenditures of $54.2K. FCF margin is -21.3%.
How does SSII compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -32.3% (avg: 12%), ROE -6.6% (avg: 15%), current ratio 2.54 (avg: 2).